Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
vYF yellow fever vaccine in adults
NCT07002060Phase 3Completed
- Sponsor
- Sanofi
- Start
- May 2025
- Primary completion
- Jan 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of SP0218 in yellow fever, sponsored by Sanofi. Started May 2025; status: completed.
02
Drugs
SP0218
03
Conditions
yellow fever
Beyond the preview
Go deeper on NCT07002060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07002060.